CNBCLean R·
Eli Lilly to buy Merida Biosciences in deal worth up to $2.88 billion
Eli Lilly plans to buy privately held Merida Biosciences for up to $2.88 billion in cash.
Read at CNBC →
Business · 1 sources covering this
Eli Lilly to buy Merida Biosciences in deal worth up to $2.88 billion
Eli Lilly plans to buy privately held Merida Biosciences for up to $2.88 billion in cash.
Coverage spectrum
0 L · 0 C · 1 R
How 1 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://statesidedaily.com/embed/cluster/78a4a1b605c437a0206ef7e670d5dc8c704c215f" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Eli Lilly to buy Merida Biosciences in deal worth up to $2.88 billion"></iframe>
